Related Experiment Video
Updated: May 9, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Adiposity rebound is misclassified by BMI rebound
S Plachta-Danielzik1, A Bosy-Westphal, B Kehden
1Institute of Human Nutrition and Food Science, Christian-Albrechts University, Kiel, Germany.
European Journal of Clinical Nutrition
|July 18, 2013
Summary
Adiposity rebound (AR) timing differs between body mass index (BMI) and fat mass index (FMI). Fat mass rebound, not BMI rebound, should define AR for accurate obesity prevention strategies.
Area of Science:
- Pediatric endocrinology
- Childhood obesity research
- Body composition analysis
Background:
- Adiposity rebound (AR) is the nadir of body mass index (BMI) percentiles between ages 3-7.
- Early AR is a risk factor for childhood obesity, making it a target for prevention.
- BMI does not fully represent body composition, necessitating investigation of fat mass index (FMI) and fat-free mass index (FFMI).
Purpose of the Study:
- To investigate the rebound patterns of FMI and FFMI alongside BMI in children.
- To determine if AR, as defined by BMI, accurately reflects changes in body fat.
Main Methods:
- Pooled cross-sectional data from 19,264 children aged 3-11 years from three German studies.
- Height and weight measurements were taken.
- Fat mass (FM) and fat-free mass (FFM) were determined using bioelectrical impedance analysis and analyzed with a population-specific algorithm. BMI, FMI, and FFMI percentiles were constructed using the LMS method.
Main Results:
- Both BMI and FMI percentiles exhibited a rebound, while FFMI percentiles showed a consistent increase with age.
- FMI rebound occurred approximately 1.6-1.8 years later than BMI rebound on the 90th percentile (P90) in both boys and girls.
- At AR, the increase in BMI-P90 slope was primarily driven by FFMI, not FMI. Conversely, at FMI rebound, the BMI slope was strongly correlated with FMI.
Conclusions:
- BMI rebound does not equate to fat mass rebound.
- The increase in BMI during AR is influenced by fat-free mass, not fat mass.
- Adiposity rebound should be redefined based on fat mass index rebound rather than BMI rebound for more accurate obesity risk assessment and prevention.
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Metabolic States of the Body: The Absorptive State
During the absorptive state, which lasts approximately four hours after a meal, the body absorbs nutrients from the gastrointestinal tract. The carbohydrates, proteins, and lipids we consume are broken down into monosaccharides, amino acids, and free fatty acids for absorption. While carbohydrates and proteins are absorbed as-is, lipids are absorbed in their broken-down forms and then re-esterified into triglycerides within enterocytes before being packaged into chylomicrons. These absorbed...
